List of Schedule I controlled substances (U.S.)
A list of substances under control by the Controlled Substances Act of 1970
This is the list of Schedule I controlled substances in the United States as defined by the Controlled Substances Act .[ 1] The following findings are required for substances to be placed in this schedule:[ 2]
The drug or other substance has a high potential for abuse.
The drug or other substance has no currently accepted medical use in treatment in the United States.
There is a lack of accepted safety for use of the drug or other substance under medical supervision.
The complete list of Schedule I substances is as follows.[ 1] The Administrative Controlled Substances Code Number for each substance is included.
Opioids
Opium derivatives
Hallucinogenic or psychedelic substances
ACSCN
Drug
7249
α-ET [ 30]
7391
4-bromo-2,5-dimethoxy-amphetamine [ 31]
7392
2C-B [ 32]
7396
2,5-dimethoxyamphetamine (2,5-DMA)[ 31]
7399
DOET [ 33]
7348
2C-T-7 [ 34]
7411
4-methoxyamphetamine (PMA)[ 31]
7401
5-methoxy-3,4-methylenedioxyamphetamine (MMDA)[ 4] [ note 1]
7395
4-methyl-2,5-dimethoxyamphetamine (DOM; STP)[ 4] [ note 1]
7400
3,4-methylenedioxyamphetamine (MDA)[ 4] [ note 1]
7405
3,4-methylenedioxymethamphetamine (MDMA )[ 35]
7404
3,4-methylenedioxy-N-ethylamphetamine (MDEA; MDE)[ 36]
7402
N-hydroxy-3,4-methylenedioxyamphetamine (N-hydroxy MDA)[ 36]
7390
3,4,5-trimethoxyamphetamine (TMA)[ 4] [ note 1]
7431
5-MeO-DMT [ 37]
7432
Alpha-methyltryptamine (αMT)[ 38]
7433
Bufotenine [ 4] [ note 1]
7434
Diethyltryptamine (DET)[ 4] [ note 1]
7435
Dimethyltryptamine (DMT)[ 4] [ note 1]
7439
5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts and salts of isomers[ 38]
7260
Ibogaine [ 4] [ note 1]
7315
Lysergic acid diethylamide (LSD)[ 4] [ note 1]
7360
Marihuana [ 4] [ note 1]
7381
Mescaline [ 4] [ note 1]
7374
Parahexyl [ 39]
7415
Peyote [ 4] [ note 1]
7482
N-ethyl-3-piperidyl benzilate [ 4] [ note 1]
7484
N-methyl-3-piperidyl benzilate [ 4] [ note 1]
7437
Psilocybin [ 4] [ note 1]
7438
Psilocin [ 4] [ note 1]
7370
Tetrahydrocannabinol (THC )
7455
Ethylamine analog of phencyclidine (Eticyclidine; PCE)
7458
Pyrrolidine analog of phencyclidine (PCPy)
7470
Thiophene analog of phencyclidine (TCP)
7473
1-[1-(2-thienyl)cyclohexyl]pyrrolidine (TCPy)
1259
3-Methylmethcathinone (3-MMC)[ 40]
1248
4-Methylmethcathinone (Mephedrone )
7535
3,4-methylenedioxypyrovalerone (MDPV )
7509
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E )
7508
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D )
7519
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C )
7518
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I )
7385
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2 )
7532
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4 )
7517
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H )
7521
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N )
7524
2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P )
7540
3,4-Methylenedioxy-N-methylcathinone (methylone )
Depressants
Stimulants
ACSCN
Drug
1585
Aminorex (aminoxaphen; 2-amino-5-phenyl-2- oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine)
7493
N-benzylpiperazine (some other names: BZP; 1-benzylpiperazine), its optical isomers, salts and salts of isomers
1235
Cathinone
1503
Fenethylline
1237
Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers
1590
(±)-cis-4-methylaminorex
1475
N-ethylamphetamine
1480
N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine)
7543
N-Ethylpentylone (ephylone, N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone))[ 41]
7246
N-Ethylhexedrone [ 42] (hexen)
7544
alpha-Pyrrolidinohexanophenone (α-PHP)[ 42]
7551
alpha-Pyrrolidinoisohexanophenone (also known as α-PHiP; α-PiHP) [ 40]
7245
4-Methyl-alpha-ethylaminopentiophenone (4-MEAP)[ 42]
7446
4'-Methyl-alpha-pyrrolidinohexiophenone (MPHP)[ 42]
7548
alpha-Pyrrolidinoheptaphenone (PV8)[ 42]
7443
4-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-α-PVP)[ 42]
1233
3-Fluoro-N-methylcathinone (3-FMC; 1-(3-fluorophenyl)-2-(methylamino)propan-1-one)
1238
4-Fluoro-N-methylcathinone (4-FMC, flephedrone, 1-(4-fluorophenyl)-2-(methylamino)propan-1-one)
1246
Pentedrone (α-methylaminovalerophenone, 2-(methylamino)-1-phenylpentan-1-one)
1249
4-Methyl-N-ethylcathinone (4-MEC, 2-(ethylamino)-1-(4-methylphenyl)propan-1-one)
1258
Naphyrone (naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one)
7498
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP, MePPP, 4-methyl-α-pyrrolidinopropiophenone,1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one)
7541
Butylone (bk-MBDB, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one)
7542
Pentylone (bk-MBDP, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one)
7545
alpha-pyrrolidinopentiophenone (α-PVP, α-pyrrolidinovalerophenone, 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one)
7546
alpha-pyrrolidinobutiophenone (α-PBP, 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one)
Cannabimimetic agents
ACSCN
Drug
7297
5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497 )
7298
5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog)
7118
1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678)
7173
1-butyl-3-(1-naphthoyl)indole (JWH-073 )
7019
1-hexyl-3-(1-naphthoyl)indole (JWH-019 )
7200
1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200 )
6250
1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250 )
7081
1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081 )
7122
1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122 )
7398
1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398 )
7201
1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201 )
7694
1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694 )
7104
1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4 )
7008
1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole 7008 (SR-18 and RCS-8 )
7203
1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203 )
7144
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (UR-144 , 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole)
7011
[1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (5-fluoro-UR-144, 5-F-UR-144, XLR-11 , 1-(5-fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole)
7048
N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (APINACA , AKB-48)
7222
Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (QUPIC , PB-22)[ 43]
7225
Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22 )[ 43]
7012
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA )[ 43]
7035
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA )[ 43]
7031
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA )[ 44]
7023
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA )[ 44]
7024
[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201 )[ 44]
7034
2-(1-(5-Fluoropentyl)-1H -indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-ADB , 5F-MDMB-PINACA)[ 45]
7033
Methyl 2-(1-(5-fluoropentyl)-1H -indazole-3-carboxamido)-3-methylbutanoate (5F-AMB )[ 45]
7049
N -(Adamantan-1-yl)-1-(5-fluoropentyl)-1H -indazole-3-carboxamide (5F-APINACA , 5F-AKB48)[ 45]
7010
N -(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H -indazole-3-carboxamide (ADB-FUBINACA )[ 45]
7042
Methyl 2-(1-(cyclohexylmethyl)-1H -indole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-CHMICA , MMB-CHMINACA)[ 45]
7020
Methyl 2-(1-(4-fluorobenzyl)-1H -indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-FUBINACA )[ 45]
7032
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA )[ 46]
7036
ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-EDMB-PINACA )[ 47]
7041
methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA )[ 47]
7047
N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (FUB-AKB48; FUB-APINACA ; AKB48 N-(4-FLUOROBENZYL))[ 47]
7083
1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (5F-CUMYL-PINACA ; SGT-25)[ 47]
7014
(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (FUB-144 )[ 47]
7021
Methyl 2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate (FUB–AMB, MMB– FUBINACA, AMB–FUBINACA )
7025
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide)
7044
MMB-CHMICA (AMB-CHMICA, methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate)
7085
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3-carboxamide)
7089
4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78)
7221
NM-2201 (CBL2201, Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate)
7027
ADB-BUTINACA (N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butyl-1H-indazole-3-carboxamide)[ 40]
See also
Notes
References
^ a b 21 CFR 1308.11 Archived 2009-08-27 at the Wayback Machine (CSA Sched I) with changes through 77 FR 64032 (Oct 18, 2012). Retrieved September 6, 2013.
^ 21 U.S.C. § 812(b)(1) United States Code via Cornell University 's Legal Information Institute . Retrieved on 2007-10-02.
^ a b c d e Lawn, John (May 29, 1987). "Schedules of Controlled Substances: Placement of Alpha-Acetyl-Methylfentanyl, Alpha-methylthiofentanyl, Beta-hydroxyfentanyl, 3-Methylthiofentanyl, Para-fluorofentanyl, and Thiofentanyl into Schedule I" (PDF) . Isomer Design . Drug Enforcement Administration . Archived from the original (PDF) on July 28, 2019. Retrieved September 6, 2023 .
^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf bg bh bi bj bk bl bm bn bo bp bq br bs bt bu bv bw bx by Bartels Jr., John R. (June 20, 1974). "PART 1308— SCHEDULES OF CONTROLLED SUBSTANCES: Annual Publication" (PDF) . Government Publishing Office . Drug Enforcement Administration . Archived from the original (PDF) on September 6, 2023. Retrieved September 6, 2023 .
^ Rosenberg, Chuck (June 7, 2017). "Schedules of Controlled Substances: Placement of Acetyl Fentanyl Into Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 9, 2023 .
^ a b c d Dhillon, Uttam (November 29, 2018). "Schedules of Controlled Substances: Placement of Furanyl Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 9, 2023 .
^ Rosenberg, Chuck (May 16, 2016). "Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 6, 2023 .
^ Bonner, Robert (August 18, 1993). "Schedules of Controlled Substances: Transfer of Levo-alpha-acetylmethadol from Schedule I to Schedule II" (PDF) . Federal Register . Drug Enforcement Administration . Archived from the original (PDF) on July 28, 2019. Retrieved September 6, 2023 .
^ Mullen, Jr., Francis M. (September 22, 1981). "Schedules of Controlled Substances: Placement of Alpha-methylfentanyl in Schedule I" (PDF) . Isomer Design . Drug Enforcement Administration . Archived from the original (PDF) on July 28, 2019. Retrieved September 6, 2023 .
^ Lawn, John (January 8, 1988). "Schedules of Controlled Substances: Placement of Beta-Hydroxy-3-Methylfentanyl in Schedule I" (PDF) . Isomer Design . Drug Enforcement Administration . Archived from the original (PDF) on July 28, 2019. Retrieved September 6, 2023 .
^ Dhillon, Uttam (May 8, 2019). "Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl in Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 9, 2023 .
^ a b c d e f g h i j k l Evans, D. Christopher (April 27, 2021). "Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances in Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 6, 2023 .
^ Milgram, Anne (April 5, 2023). "Schedules of Controlled Substances: Placement of Brorphine in Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 6, 2023 .
^ a b Patterson, Robert (April 20, 2018). "Schedules of Controlled Substances: Placement of Butyryl Fentanyl and U-47700 Into Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 9, 2023 .
^ Shea, TImothy (October 2, 2020). "Schedules of Controlled Substances: Placement of Crotonyl Fentanyl in Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 9, 2023 .
^ a b c d Evans, D. Christopher (March 31, 2021). "Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I; Correction" . Federal Register . Drug Enforcement Administration . Retrieved September 9, 2023 .
^ a b Dhillon, Uttam (October 25, 2019). "Schedules of Controlled Substances: Placement of Cyclopropyl Fentanyl, Methoxyacetyl fentanyl, ortho-Fluorofentanyl, and para-Fluorobutyryl Fentanyl in Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 9, 2023 .
^ Jenson, Jerry (May 7, 1975). "Schedules of Controlled Substances: Placement of Difenoxin in Schedule I" (PDF) . Isomer Design . Drug Enforcement Administration . Archived from the original (PDF) on July 28, 2019. Retrieved September 6, 2023 .
^ a b c d e Evans, D. Christopher (May 4, 2021). "Schedules of Controlled Substances: Placement of Four Specific Fentanyl-Related Substances in Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 9, 2023 .
^ Milgram, Anne (November 4, 2021). "Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 9, 2023 .
^ Milgram, Anne (August 18, 2023). "Schedules of Controlled Substances: Placement of Metonitazene in Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved November 3, 2023 .
^ a b Lawn, John (January 23, 1987). "Placement of MPPP and PEPAP in Schedule I" (PDF) . Isomer Design . Drug Enforcement Administration . Archived from the original (PDF) on July 18, 2019. Retrieved September 9, 2023 .
^ Patterson, Robert (December 13, 2017). "Schedules of Controlled Substances: Placement of MT-45 Into Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 9, 2023 .
^ Evans, D. Christopher (March 31, 2021). "Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I; Correction" . Federal Register . Drug Enforcement Administration . Retrieved September 29, 2023 .
^ Ingersoll, John (January 25, 1972). "Control of Propiram" (PDF) . Isomer Design . Bureau of Narcotics and Dangerous Drugs. Archived from the original (PDF) on July 18, 2019. Retrieved September 30, 2023 .
^ Bensinger, Peter (September 19, 1980). "Placement of Sufentanil and Tilidine in Schedule I" (PDF) . Isomer Design . Drug Enforcement Administration . Archived from the original (PDF) on July 28, 2019. Retrieved September 30, 2023 .
^ Milgram, Anne (November 21, 2022). "Schedules of Controlled Substances: Placement of Zipeprol in Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 30, 2023 .
^ Ingersoll, John (June 27, 1972). "Control of Drotebanol" (PDF) . Isomer Design . Bureau of Narcotics and Dangerous Drugs. Archived from the original (PDF) on March 3, 2022. Retrieved September 30, 2023 .
^ Bartels, Jr., John R. (March 29, 1974). "Etorphine Hydrochloride Transfer to Schedule II" (PDF) . Isomer Design . Drug Enforcement Administration . Archived from the original (PDF) on March 3, 2022. Retrieved September 30, 2023 .
^ Greene, Stephen (September 12, 1994). "Schedules of Controlled Substances; Placement of Alpha-Ethyltryptamine Into Schedule I" . Federal Register through the Government Publishing Office . Drug Enforcement Administration . Retrieved September 30, 2023 .
^ a b c Bartels, Jr., John R. (September 14, 1973). "Additions to Schedule I" (PDF) . Isomer Design . Drug Enforcement Administration . Archived from the original (PDF) on March 3, 2022. Retrieved September 30, 2023 .
^ Greene, Stephen (June 2, 1995). "Schedules of Controlled Substances; Placement of 4-Bromo-2,5-Dimethoxyphenethylamine Into Schedule I" . Federal Register . Drug Enforcement Administration . Retrieved September 30, 2023 .
^ Bonner, Robert (January 14, 1993). "Placement of Cathinone and 2,5-dimethoxy-4-ethylamphetamine (DOET) into Schedule I" (PDF) . Isomer Design . Drug Enforcement Administration . Archived from the original (PDF) on September 26, 2021. Retrieved November 3, 2023 .
^ Leonhart, Michele (March 18, 2004). "Schedules of Controlled Substances; Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine Into Schedule I of the Controlled Substances Act" . Federal Register . Drug Enforcement Administration . Retrieved November 3, 2023 .
^ Lawn, John (February 22, 1988). "Scheduling of 3,4-methylenedioxymethamphetamine (MDMA) into Schedule I of the Controlled Substances Act; Remand" (PDF) . Isomer Design . Drug Enforcement Administration . Archived (PDF) from the original on March 3, 2022. Retrieved November 3, 2023 .
^ a b Lawn, John (April 13, 1989). "Placement of 3,4-Methylenedioxy-N-ethylamphetamine and N-hydroxy-3,4-methylenedioyamphetamine into Schedule I" (PDF) . Isomer Design . Drug Enforcement Administration . Archived (PDF) from the original on March 3, 2022. Retrieved August 3, 2024 .
^ Leonhart, Michele (December 20, 2010). "Placement of 5-Methoxy-N,N-Dimethyltryptamine into Schedule I of the Controlled Substances Act" . Federal Register . Drug Enforcement Administration . Retrieved August 3, 2024 .
^ a b Leonhart, Michele (September 29, 2004). "Placement of Alpha-Methyltryptamine and 5-Methoxy-N,N-Diisopropyltryptamine Into Schedule I of the Controlled Substances Act" . Federal Register . Drug Enforcement Administration . Retrieved August 3, 2024 .
^ Lawn, John (November 22, 1982). "Placement of Parahexyl into Schedule I" (PDF) . Isomer Design . Drug Enforcement Administration . Archived from the original (PDF) on May 19, 2024. Retrieved August 3, 2024 .
^ a b c "Specific Listing for Three Currently Controlled Schedule I Substances" . Federal Register . DEA. Retrieved 27 January 2024 .
^ "Schedules of Controlled Substances: Temporary Placement of N-Ethylpentylone in Schedule I" . Drug Enforcement Administration.
^ a b c d e f "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I" . Drug Enforcement Administration.
^ a b c d Drug Enforcement Administration, Department of Justice (Feb 10, 2014). "Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order". Fed. Regist . 79 (27): 7577–7582. PMID 24605391 .
^ a b c Drug Enforcement Administration, Department of Justice (2015). "Schedules of controlled substances: Temporary placement of three synthetic cannabinoids into schedule I. Final order". Federal Register . 80 (20): 5042–7. PMID 25730924 .
^ a b c d e f "Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) Into Schedule I" . Drug Enforcement Administration .
^ Drug Enforcement Administration, Department of Justice (2018). "Schedules of Controlled Substances: Extension of Temporary Placement of MAB–CHMINACA in Schedule I of the Controlled Substances Act. Temporary rule; temporary scheduling order; extension". Federal Register . 83 (20): 4411–2. PMID 29461023 .
^ a b c d e "Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I" . Federal Register.
External links